Form 4: Orthofix Director Vickie Capps Awarded Over 18,000 Deferred Stock Units

Orthofix Medical Inc. Director Vickie L. Capps has been granted 18,841 deferred stock units, aligning her interests with shareholders through future equity vesting.

Summary

• Vickie L. Capps, a Director of Orthofix Medical Inc. (OFIX), was awarded 18,841 deferred stock units (DSUs) on June 18, 2025.
• These DSUs represent a contingent right to receive one share of Orthofix common stock each.
• The award vests in full on the first anniversary of the grant date, provided Ms. Capps continues her service to the company.
• Upon vesting, the DSUs will convert into common stock within 45 days of Ms. Capps' termination of service.
• Following this transaction, Ms. Capps' total beneficial ownership of Orthofix securities will be 21,934 shares, which includes 3,093 previously reported deferred stock units.

Sentiment

Score: 7

Explanation: The award of deferred stock units to a director is a standard practice that aligns management's interests with shareholders, generally viewed as a positive for corporate governance and long-term value creation, without indicating any immediate negative implications for the company's operations or financial health.

Positives

• The award of deferred stock units to Director Vickie L. Capps aligns her long-term interests with those of Orthofix Medical Inc. shareholders.
• Equity-based compensation is a common practice to incentivize directors and retain talent.

Negatives

• The award of deferred stock units, while common, represents a dilution potential upon conversion to common stock, though this is typically factored into compensation plans.

Risks

• The vesting of the deferred stock units is contingent on the reporting person's continued service through the vesting date, meaning the award could be forfeited if service terminates prematurely.

Industry Context

Equity awards, such as deferred stock units, are a standard component of director compensation across various industries, including the medical device sector, designed to align leadership incentives with long-term company performance and shareholder value.

Related Party Transactions

• The award of 18,841 deferred stock units to Vickie L. Capps, a Director of Orthofix Medical Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The award aligns the director's interests with shareholders, potentially leading to better long-term decision-making. However, it also represents potential future dilution upon conversion of DSUs to common stock.
• Employees: No direct impact on general employees is indicated.

Next Steps

• The deferred stock units are expected to vest on the first anniversary of the grant date (approximately June 18, 2026), subject to continued service.
• Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Key Dates

Keywords

Orthofix Medical Inc., OFIX, SEC Form 4, Insider Transaction, Deferred Stock Units, DSU, Equity Award, Director Compensation, Vickie L. Capps, Stock Grant